Palleos successfully executed a challenging three-arm, randomized, placebo-controlled Phase 3 study in Ulcerative Colitis. Despite strict inclusion criteria and limited patient pool, the Palleos team overcame recruitment challenges by expanding to new regions (Lebanon, Jordan), implementing referral programs, and optimizing site engagement. Palleos innovative approach delivered results in this complex indication.
Need clinical research solutions for your next trial? Contact us at info@palleos.com.
